[{"NetIncomeLoss_1_Q2_USD":9231000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":86503000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":-932000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":-1842000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q2_USD":156375000.0,"ProductWarrantyAccrual_0_Q2_USD":3495000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_1_Q2_USD":0.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":176759000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_2_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-380000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":51900000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":278000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":556000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-689000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":9985000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-109000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":18855000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":54800000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":3952000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-2212000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":14092000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":312000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":28000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":37000.0,"PaymentsToAcquireAvailableForSaleSecurities_2_Q2_USD":32939000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":29435000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":90636000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":1059337.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":1075333.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":150000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":299000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":779000.0,"GoodwillImpairmentLoss_2_Q2_USD":0.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":170434000.0,"GoodwillOtherIncreaseDecrease_2_Q2_USD":-263000.0,"IncreaseDecreaseInInventories_2_Q2_USD":41543000.0,"ProductWarrantyAccrualPayments_2_Q2_USD":773000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":37564881.0,"FinanceLeasePrincipalPayments_2_Q2_USD":692000.0,"InventoryWriteDown_2_Q2_USD":1951000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":291000.0,"ProductWarrantyAccrualClassifiedCurrent_0_Q2_USD":3495000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":67810000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":37582348.0,"ProceedsFromSaleOfAvailableForSaleSecurities_2_Q2_USD":2000000.0,"EarningsPerShareBasic_2_Q2_USD":0.58,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":4268000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":77000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":24.08,"ResearchAndDevelopmentExpense_1_Q2_USD":17738000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":35814000.0,"EarningsPerShareBasic_1_Q2_USD":0.25,"ProceedsFromStockPlans_2_Q2_USD":7354000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-1884000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-408000.0,"AvailableForSaleSecuritiesCurrent_0_Q2_USD":156722000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q2_USD":0.0,"ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_2_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":559000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":58000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q2_USD":87334000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":-0.187,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.152,"DepreciationDepletionAndAmortization_2_Q2_USD":7022000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q2_USD":69121000.0,"Revenues_1_Q2_USD":184258000.0,"Revenues_2_Q2_USD":353462000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":58000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":1904000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":3445000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":754000.0,"ShareBasedCompensation_2_Q2_USD":16198000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":53200000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_2_Q2_USD":1600000.0,"CostOfRevenue_1_Q2_USD":65572000.0,"CostOfRevenue_2_Q2_USD":123439000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":87601000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":36523011.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":36489548.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":64126000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":3500000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-17678000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-1832000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":10138000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":6988000.0,"Goodwill_0_Q2_USD":8109000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_0_Q2_USD":0.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":1309000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":863000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":82277000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":978000.0,"DeferredIncomeTaxesAndTaxCredits_2_Q2_USD":2570000.0,"NetIncomeLoss_2_Q2_USD":21067000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-93000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":2236000.0,"OperatingLeasePayments_2_Q2_USD":3914000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":9895000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":7354000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":70244.0,"LesseeOperatingLeaseDiscountRate_0_Q2_pure":0.047,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":673376000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q2_USD":25227000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":58000.0,"GrossProfit_1_Q2_USD":118686000.0,"GrossProfit_2_Q2_USD":230023000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":14488000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_0_Q2_USD":25227000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":9053000.0,"EarningsPerShareDiluted_1_Q2_USD":0.25,"OtherSundryLiabilitiesCurrent_0_Q2_USD":11103000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":14163000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":405000.0,"InventoryNet_0_Q2_USD":254977000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":2153000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":10203000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":22670000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":13.92,"OperatingIncomeLoss_1_Q2_USD":10312000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":184258000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":353462000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":5843000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q2_USD":69041000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":19.07,"OperatingIncomeLoss_2_Q2_USD":23775000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":52687000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":16198000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":9803000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":22898000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":12607000.0,"ForeignEarningsRepatriated_1_Q2_USD":7300000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":950584.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":156375000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":7286000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"ProfitLoss_1_Q2_USD":8299000.0,"ProfitLoss_2_Q2_USD":19225000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":54444000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":5020000.0,"OperatingExpenses_1_Q2_USD":108374000.0,"OperatingExpenses_2_Q2_USD":206248000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1400000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":150.0,"EarningsPerShareDiluted_2_Q2_USD":0.56,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":17013000.0,"Ticker":"PEN","CIK":"1321732","name":"PENUMBRA INC","OfficialName":"Penumbra Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"7821675869.0","Country":"nan","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NYSE","SP500":"nan","filed":"20210809"}]